Featured Research

from universities, journals, and other organizations

Research could help improve early diagnosis of prostate cancer

Date:
February 25, 2014
Source:
University of Essex
Summary:
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project. Currently, is it difficult to distinguish between benign and aggressive malignant tumors, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety. Scientists in this field have been looking to find biomarkers to distinguish between the two types of tumors, and now prostate cancer experts have found an important link between the molecule known as BORIS and malignant tumors.

Professor Elena Klenova in her lab.
Credit: Image courtesy of University of Essex

Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.

Currently, is it difficult to distinguish between benign and aggressive malignant tumors, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety.

Scientists in this field have been looking to find biomarkers to distinguish between the two types of tumors, and now prostate cancer experts at Essex have found an important link between the molecule known as BORIS and malignant tumors.

The research, published in the February issue of the journal Prostate, could lead the way for pathologists to have better tools for the early diagnosis of prostate cancer and for patients to get the most appropriate level of treatment for them.

The major three-year study involved the University-based Essex Biomedical Sciences Institute (EBSI) working with the Colchester Catalyst Charity and the Urology and Pathology Departments at Colchester Hospital University NHS Foundation Trust.

Leading the project at Essex was Professor Elena Klenova, who was part of the scientific team which first discovered BORIS in 2002 and its importance in prostate cancer research.

"Apart from playing an important role in the development of sperm in men, BORIS is not usually expressed in the body," explained Professor Klenova, "However, it does appear in malignant tumors, which is why it is seen as an important molecule in the development of cancer. It also can help distinguish between normal and cancerous cells."

Prostate cancer is the most common type of cancer in men. Around 37,000 UK men are diagnosed with the disease each year. Many prostate cancers develop very slowly, but in a small proportion of cases the cancer grows more quickly and spreads to other areas of the body, sometimes proving fatal.

The research was co- funded by the Colchester Catalyst Charity as part of its ongoing mission to improve the health care of people living in north-east Essex. However, the study's findings obviously have a wider impact generally for the treatment and the understanding of prostate cancer.

Professor Klenova's team at Essex, which included Zubair Cheema and Yukti Hari-Gupta, sponsored by Colchester Hospital University NHS Foundation Trust and the Colchester Catalyst Charity, respectively, looked at levels of BORIS in benign and malignant tumors and found that it was only present in malignant tumors, suggesting that the molecule could prove to be a useful biomarker for aggressive symptoms of the disease.

John Corr, consultant urological surgeon at Colchester Hospital University NHS Foundation Trust, said: "Collaborative work like this between a university and an acute hospital trust is a very under-utilised resource in the NHS, and I am very happy to be involved in it.

"This is a very exciting finding and will help in our daily fight against prostate cancer. It may more accurately identify those patients that need active treatment and aid in predicting long-term outcomes."

The scientists will now investigate the link between BORIS and malignant tumors further with a bigger study.


Story Source:

The above story is based on materials provided by University of Essex. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zubair Cheema, Yukti Hari-Gupta, Georgia-Xanthi Kita, Dawn Farrar, Ian Seddon, John Corr, Elena Klenova. Expression of the cancer-testis antigen BORIS correlates with prostate cancer. The Prostate, 2014; 74 (2): 164 DOI: 10.1002/pros.22738

Cite This Page:

University of Essex. "Research could help improve early diagnosis of prostate cancer." ScienceDaily. ScienceDaily, 25 February 2014. <www.sciencedaily.com/releases/2014/02/140225101252.htm>.
University of Essex. (2014, February 25). Research could help improve early diagnosis of prostate cancer. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2014/02/140225101252.htm
University of Essex. "Research could help improve early diagnosis of prostate cancer." ScienceDaily. www.sciencedaily.com/releases/2014/02/140225101252.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins